Synthesis and Characterization of Acylated Polycaprolactone (PCL) Nanospheres and Investigation of Their Influence on Aggregation of Amyloid Proteins

References

• Ghahghaei, A.; Faridi, N. Review: structure of amyloid fibril in diseases. J. Biomed. Sci. Eng. 2009, 2, 345.
   Google Scholar
• Serpell, L.C. Alzheimer's amyloid fibrils: structure and assembly. Biochimi. Biophys. Acta (BBA)-Molec Basis Dis. 2000, 1502, 16.
   PubMed Web of Science ®Google Scholar
• Greenwald, J.; Riek, R. Biology of amyloid: structure, function, and regulation. Structure. 2010, 18, 1244.
   PubMed Web of Science ®Google Scholar
• Ramírez-Alvarado, M.; Merkel, J.S.; Regan, L. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. 2000, 97, 8979.
   PubMed Web of Science ®Google Scholar
• Dobson, C.M. Protein folding and misfolding. Nature. 2003, 426, 884.
   PubMed Web of Science ®Google Scholar
• Sakono, M.; Zako, T.; Ueda, H.; Yohda, M.; Maeda, M. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J. 2008, 275, 5982.
   PubMed Web of Science ®Google Scholar
• Berhanu, W.M.; Masunov, A.E. Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer. Biophys. Chem. 2010, 149, 12.
   PubMed Web of Science ®Google Scholar
• Stefani, M.; Rigacci, S. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int. J. Mol. Sci. 2013, 14, 12411.
   PubMed Web of Science ®Google Scholar
• Harper, J.D.; Wong, S.S.; Lieber, C.M.; Lansbury, P.T. Assembly of Aβ amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry. 1999, 38, 8972.
   PubMed Web of Science ®Google Scholar
• Spuch, C.; Saida, O.; Navarro, C. Advances in the treatment of neurodegenerative disorders employing nanoparticles. Recent Pat. Drug Deliv. Formul. 2012, 6, 2.
   PubMedGoogle Scholar
• Sahni, J.K.; Doggui, S.; Ali, J.; Baboota, S.; Dao, L.; Ramassamy, C. Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J. Control. Release. 2011, 152, 208.
   PubMed Web of Science ®Google Scholar
• Colvin, V.L.; Kulinowski, K.M. Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. 2007, 104, 8679.
   PubMed Web of Science ®Google Scholar
• Auer, S.; Trovato, A.; Vendruscolo, M. A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation. PLoS Comput. Biol. 2009, 5, 1000458.
   PubMed Web of Science ®Google Scholar
• Linse, S.; Cabaleiro-Lago, C.; Xue, W.-F.; Lynch, I.; Lindman, S.; Thulin, E. et al. Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. 2007, 104, 8691.
   PubMed Web of Science ®Google Scholar
• Wu, W.h.; Sun, X.; Yu, Y.p.; Hu, J.; Zhao, L.; Liu, Q. et al. TiO2 nanoparticles promote β-amyloid fibrillation in vitro. Biochem. Biophys. Res. Commun. 2008, 373, 315.
   PubMed Web of Science ®Google Scholar
• Pai, A.S.; Rubinstein, I.; Önyüksel, H. PEGylated phospholipid nanomicelles interact with β-amyloid (1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro. Peptides. 2006, 27, 2858.
   PubMed Web of Science ®Google Scholar
• Kim, J.E.; Lee, M. Fullerene inhibits β-amyloid peptide aggregation. Biochem. Biophys. Res. Commun. 2003, 303, 576.
   PubMed Web of Science ®Google Scholar
• Rocha, S.; Thünemann, A.F.; Pereira, M.d. C.; Coelho, M.; Möhwald, H.; Brezesinski, G. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Biophys Chem. 2008, 137, 35.
   PubMed Web of Science ®Google Scholar
• Lindman, S.; Lynch, I.; Thulin, E.; Nilsson, H.; Dawson, K.A.; Linse, S. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano. Lett. 2007, 7, 914.
   PubMed Web of Science ®Google Scholar
• Gabriel, M.; van Nieuw Amerongen, G.P.; van Hinsbergh, V.W.; van Nieuw Amerongen, A.V.; Zentner, A. Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films. J. Biomater. Sci. Polym. Ed. 2006, 17, 567.
   PubMed Web of Science ®Google Scholar
• Zhu, Y.; Gao, C.; Liu, X.; Shen, J. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules. 2002, 3, 312.
   PubMed Web of Science ®Google Scholar
• Yuan, S.; Xiong, G.; Wang, X.; Zhang, S.; Choong, C. Surface modification of polycaprolactone substrates using collagen-conjugated poly (methacrylic acid) brushes for the regulation of cell proliferation and endothelialisation. J. Mater. Chem. 2012, 22, 13039.
   Web of Science ®Google Scholar
• Ma, G.; Yang, D.; Kennedy, J.F.; Nie, J. Synthesize and characterization of organic-soluble acylated chitosan. Carbohyd. Polym. 2009, 75, 390.
   Web of Science ®Google Scholar
• Tuli, R.A.; George, G.A.; Dargaville, T.R.; Islam, N. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations. Pharma. Res. 2012, 29, 2445.
   Web of Science ®Google Scholar
• Khurana, R.; Coleman, C.; Ionescu-Zanetti, C.; Carter, S.A.; Krishna, V.; Grover, R.K.; Roy, R.; Singh, S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005, 151, 229.
   PubMed Web of Science ®Google Scholar